Integra LifeSciences posted second quarter revenues of $384 million, a 4.8 percent increase of the same period for last year.
Five things to know:
1. Extremity orthopedics revenues rose 1.2 percent to $22 million while the company reported an increase of 6.1 percent to $134 million in orthopedics and tissue technologies revenues compared to the second quarter of 2018.
2. The company posted 172.73 percent increase in net income to $30 million, up from $11 million for the same period last year.
3. Integra reaffirms its revenue guidance for the full-year 2019, including total reported revenues of $1.5 billion to $1.5 billion.
4. Adjusted EBIDTA margin increased 200 basis points to 25.5 percent compared to the same period for last year.
5. Compared to the same period for 2018, reported revenues increased 4.8 percent to $384 million.
Integra President and CEO Peter Arduini attributed the positive second quarter results to the strong performance of the company's portfolio and new product launches.